Strain-dependent viral dynamics and virus-cell interactions in a novel in vitro system supporting the life cycle of blood-borne hepatitis C Virus

Hepatology

Volumn 50, Issue 3, 2009, Pages 689-696

  Aly, Hussein Hassan ^a,b   Qi, Yue ^a   Atsuzawa, Kimie ^c   Usuda, Nobuteru ^c   Takada, Yasutsugu ^a   Mizokami, Masashi ^d   Shimotohno, Kunitada ^e   Hijikata, Makoto ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL HEPATOLOGY AND TROPICAL MEDICINE RESEARCH INSTITUTE   (Egypt)

^c FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Japan Kounodai Hospital   (Japan)

^e KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

APOPTOSIS; ARTICLE; CELL IMMORTALIZATION; CELL PROLIFERATION; ELECTRON MICROSCOPY; FRACTIONATION; GENOTYPE; HEPATITIS C VIRUS; IN VITRO STUDY; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; SUCROSE GRADIENT; VIRUS CELL INTERACTION; VIRUS CULTURE; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE; ANIMAL; BLOOD; CULTURE TECHNIQUE; HEPATITIS C; HUMAN; LIVER CELL; METABOLISM; PATHOGENICITY; PHYSIOLOGY; VIRION; VIROLOGY;

ANIMALS; CELL CULTURE TECHNIQUES; HEPACIVIRUS; HEPATITIS C; HEPATOCYTES; HUMANS; VIRION; VIRUS REPLICATION;

EID: 70349260291     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.23034     Document Type: Article

References (30)

1. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000;20:1-16. (Pubitemid 30421405)
2. Younossi Z, Kallman J, Kincaid J. The effects of HCV infection and management on health-related quality of life. HEPATOLOGY 2007;45:806-816. (Pubitemid 46450632)
3. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL Jr, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002;347:975-982.
4. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005;11:791-796. (Pubitemid 41021213)
5. Aly HH, Watashi K, Hijikata M, Kaneko H, Takada Y, Egawa H, et al. Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes. J Hepatol 2007;46:26-36. (Pubitemid 44827421)
6. Ikeda M, Sugiyama K, Mizutani T, Tanaka T, Tanaka K, Sekihara H, et al. Human hepatocyte clonal cell lines that support persistent replication of hepatitis C virus. Virus Res 1998;56:157-167. (Pubitemid 28414407)
7. Chong TW, Smith RL, Hughes MG, Camden J, Rudy CK, Evans HL, et al. Primary human hepatocytes in spheroid formation to study hepatitis C infection. J Surg Res 2006;130:52-57. (Pubitemid 43028564)
8. Molina S, Castet V, Pichard-Garcia L, Wychowski C, Meurs E, Pascussi JM, et al. Serum-derived hepatitis C virus infection of primary human hepatocytes is tetraspanin CD81 dependent. J Virol 2008;82:569-574. (Pubitemid 350309172)
9. El-Farrash MA, Aly HH, Watashi K, Hijikata M, Egawa H, Shimotohno K. In vitro infection of immortalized primary hepatocytes by HCV genotype 4a and inhibition of virus replication by cyclosporin. Microbiol Immunol 2007;51:127-133.
10. Mizumoto H, Ishihara K, Nakazawa K, Ijima H, Funatsu K, Kajiwara T. A new culture technique for hepatocyte organoid formation and long-term maintenance of liver-specific functions. Tissue Eng Part C Methods 2008;14:167-175. (Pubitemid 351838709)
11. Funatsu K, Ijima H, Nakazawa K, Yamashita Y, Shimada M, Sugimachi K. Hybrid artificial liver using hepatocyte organoid culture. Artif Organs 2001;25:194-200. (Pubitemid 32852967)
12. Mizumoto H, Aoki K, Nakazawa K, Ijima H, Funatsu K, Kajiwara T. Hepatic differentiation of embryonic stem cells in HF/organoid culture. Transplant Proc 2008;40:611-613.
13. Andrei G. Three-dimensional culture models for human viral diseases and antiviral drug development. Antiviral Res 2006;71:96-107. (Pubitemid 44223779)
14. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Ohkoshi S, Shimotohno K. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun 1991;175:220-228.
15. Boulestin A, Sandres-Saune K, Payen JL, Alric L, Dubois M, Pasquier C, et al. Genetic heterogeneity of the envelope 2 gene and eradication of hepatitis C virus after a second course of interferon-alpha. J Med Virol 2002;68:221-228. (Pubitemid 34936728)
16. Murakami K, Inoue Y, Hmwe SS, Omata K, Hongo T, Ishii K, et al. Dynamic behavior of hepatitis C virus quasispecies in a long-term culture of the three-dimensional radial-flow bioreactor system. J Virol Methods 2008;148:174-181.
17. Meuleman P, Hesselgesser J, Paulson M, Vanwolleghem T, Desombere I, Reiser H, et al. Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo. HEPATOLOGY 2008;48:1761-1768.
18. Kaito M, Watanabe S, Tsukiyama-Kohara K, Yamaguchi K, Kobayashi Y, Konishi M, et al. Hepatitis C virus particle detected by immunoelectron microscopic study. J Gen Virol 1994;75:1755-1760. (Pubitemid 24211260)
19. Roulston A, Marcellus RC, Branton PE. Viruses and apoptosis. Annu Rev Microbiol 1999;53:577-628.
20. Forns X, Bukh J. The molecular biology of hepatitis C virus. Genotypes and quasispecies. Clin Liver Dis 1999;3:693-716, vii.
21. Dickson RC. Clinical manifestations of hepatitis C. Clin Liver Dis 1997;1:569-585.
22. Aizaki H, Nagamori S, Matsuda M, Kawakami H, Hashimoto O, Ishiko H, et al. Production and release of infectious hepatitis C virus from human liver cell cultures in the three-dimensional radial-flow bioreactor. Virology 2003;314:16-25. (Pubitemid 37153297)
23. Mateu G, Donis RO, Wakita T, Bukh J, Grakoui A. Intragenotypic JFH1 based recombinant hepatitis C virus produces high levels of infectious particles but causes increased cell death. Virology 2008;376:397-407.
24. Li X, Jeffers LJ, Shao L, Reddy KR, de Medina M, Scheffel J, et al. Identification of hepatitis C virus by immunoelectron microscopy. J Viral Hepat 1995;2:227-234.
25. Gale M Jr, Foy EM. Evasion of intracellular host defence by hepatitis C virus. Nature 2005;436:939-945. (Pubitemid 41191669)
26. Fischer R, Baumert T, Blum HE. Hepatitis C virus infection and apoptosis. World J Gastroenterol 2007;13:4865-4872.
27. Aoki H, Hayashi J, Moriyama M, Arakawa Y, Hino O. Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1. J Virol 2000;74:1736-1741. (Pubitemid 30434030)
28. Ladu S, Calvisi DF, Conner EA, Farina M, Factor VM, Thorgeirsson SS. E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancer. Gastroenterology 2008;135:1322-1332.
29. Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis 2000;21:485-495.
30. Schulze-Bergkamen H, Krammer PH. Apoptosis in cancer - implications for therapy. Semin Oncol 2004;31:90-119.